Grand Rounds February 2, 2024: Strategies for Improving Public Understanding of FDA and the Products It Regulates…Why Should We Care, and What Might We Do? (Susan C. Winckler, RPh, Esq)
Rethinking Clinical Trials
FEBRUARY 7, 2024
This work is important because the digital health information environment and limited public trust in government institutions represent pressing challenges for FDA. Observation 5: Consistent, multi-channel messages resonate with consumers. The FDA can leverage more communications channels, messengers, and mediums to reach the public.
Let's personalize your content